NXL
NXL
NASDAQ · Health Care

Nexalin Technology Inc

$0.51
-0.11 (-16.95%)
As of Feb 8, 2:29 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 3.22M 3.31M 3.62M
Net Income 423.6K 342.9K 405.7K
EPS
Profit Margin 13.2% 10.4% 11.2%
Rev Growth +3.9% +22.5% +6.8%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 3.29M 3.24M 3.21M
Total Equity 3.21M 3.39M 3.33M
D/E Ratio 1.02 0.95 0.96
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 714.6K 846.1K 883.2K
Free Cash Flow 296.1K 192.0K 243.4K